Global Blood Testing Market Overview:
Blood tests are very common, blood tests are recommended to see how the body is working. During a blood test, a small sample of blood is taken from the body. It is generally drawn from a vein in arm using a needle or by using a finger prick. The procedure is fast and easy, though it may cause some short-term discomfort. The workers of laboratory draw the blood and analyze it. They use either whole blood to count blood cells or separate the blood cells from the fluid that contains them. This fluid is known as plasma or serum. As per latest study released by AMA Research, the Global Blood Testing market is expected to see growth rate of 8.5%
|Unit||Value (USD Million)|
|Customization Scope||Avail customization with purchase of this report. Add or modify country, region & or narrow down segments in the final scope subject to feasibility|
- Growing Occurrence of Type I As Well As Type II Diabetes
- Rise in Prevalence of Infectious Diseases
- Increasing Cost of Blood Testing
- Rise in Awareness about the Safety of Donated Blood
- Increase in Awareness among Patients about Self-Testing Products
- Constant Introduction of Movable Home Healthcare Blood Testing Kits
- The Process Can Be Uncomfortable
- Testing Is Not Always Definitive
Some of the key players profiled in the report are Abbott Laboratories (United States), Bio-Rad Laboratories Inc. (United States), Roche Holding AG (Switzerland), Quest Diagnostics (United States), Siemens Healthcare (Germany), Danaher (United States), Becton Dickinson & Company (United States), Trinity Biotech PLC (Ireland), Baxter International (United States), Novartis Diagnostics (Switzerland) and Cepheid Corporation (United States). Additionally, following companies can also be profiled that are part of our coverage like Meridian Bioscience (United States) and BioMerieux S.A. (France). Analyst at AMA Research see United States Players to retain maximum share of Global Blood Testing market by 2027. Considering Market by Test Types, the sub-segment i.e. Complete Blood Count (CBC) [Platelets, Hemoglobin, Hematocrit, Others] will boost the Blood Testing market. Considering Market by Methods, the sub-segment i.e. Manual will boost the Blood Testing market.
Latest Market Insights:
On May 14, 2019 Abbott has announced that it has partnered with the National Institutes of Health (NIH) on the BRAIN (Brain Research through Advancing Innovative Neurotechnologies) initiative to accelerate advancements in neuroscience research. Abbott will provide the company's neuromodulation technologies., On February 25, 2019, Roche and Spark Therapeutics, Inc. announced that they have entered into a definitive merger agreement for Roche to fully acquire Spark Therapeutics, a leader in discovering, developing, and delivering gene therapies with one commercial asset and four programs currently in clinical trials. and DarioHealth Corp. announced in May 2020 that its Self-test Blood Glucose Meters have been granted U.S. FDA approval, for use in hospitalized diabetic patients.
In October 2020, Siemens Healthineers announced shipping worldwide its laboratory-based total antibody test1 to detect the presence of SARS-CoV-2 IgM and IgG antibodies in the blood. The total antibody test permits the identification of patients who have developed an adaptive immune response. On March 26, 2019, Becton, Dickinson and Company, a leading global medical technology company announced the CE-IVD certification for the BD FACSDuet automated flow cytometry system, which enables clinical laboratories to improve their efficiency by reducing errors and limiting the manual user interactions required to run assays on the BD FACSLyric clinical flow cytometer.
What Can be Explored with the Blood Testing Market Study
Gain Market Understanding
Identify Growth Opportunities
Analyze and Measure the Global Blood Testing Market by Identifying Investment across various Industry Verticals
Understand the Trends that will drive Future Changes in Blood Testing
Understand the Competitive Scenario
- Track Right Markets
- Identify the Right Verticals
The top-down and bottom-up approaches are used to estimate and validate the size of the Global Blood Testing market.
In order to reach an exhaustive list of functional and relevant players various industry classification standards are closely followed such as NAICS, ICB, SIC to penetrate deep in important geographies by players and a thorough validation test is conducted to reach most relevant players for survey in Blood Testing market.
In order to make priority list sorting is done based on revenue generated based on latest reporting with the help of paid databases such as Factiva, Bloomberg etc.
Finally the questionnaire is set and specifically designed to address all the necessities for primary data collection after getting prior appointment by targeting key target audience that includes Manufacturers of Blood Testing Kits, Suppliers of Blood Testing Kits, Wholesalers, Distributors and Retailers of Blood Testing Kits, Healthcare Industry, Research Organizations and Governmental Bodies.
This helps us to gather the data related to players revenue, operating cycle and expense, profit along with product or service growth etc.
Almost 70-80% of data is collected through primary medium and further validation is done through various secondary sources that includes Regulators, World Bank, Association, Company Website, SEC filings, OTC BB, USPTO, EPO, Annual reports, press releases etc.